|
SDGR | Schrodinger, Inc. |
|
|
SDGR | Schrodinger, Inc. |
| Pharmaceutical Preparations |
| Book value per $ invested | $ 0.33 |
| Leverage | 50.84% |
| Market Cap | $ 985.6m |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -175.6m |
| Margin | -64.43% |
Schrdinger, Inc. provides a physics-based software platform that enables the discovery of novel molecules for drug development and material applications. The company is headquartered in New York, New York.